Literature DB >> 21505222

The true cost of pharmacological disease prevention.

Teppo L N Järvinen1, Harri Sievänen, Pekka Kannus, Jarkko Jokihaara, Karim M Khan.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21505222     DOI： 10.1136/bmj.d2175

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Both falling and bone fragility should be targeted to prevent hip fracture in older adults.

Authors:  T Sugiyama; Y T Kim; H Oda
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

2.  Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors.

Authors:  F Douglas; K J Petrie; T Cundy; A Horne; G Gamble; A Grey
Journal:  Osteoporos Int       Date:  2011-11-08       Impact factor: 4.507

3.  Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women.

Authors:  T Pekkarinen; E Löyttyniemi; M Välimäki
Journal:  Osteoporos Int       Date:  2013-05-08       Impact factor: 4.507

Review 4.  Unmasking the surgeons: the evidence base behind the use of facemasks in surgery.

Authors:  Charlie Da Zhou; Pamela Sivathondan; Ashok Handa
Journal:  J R Soc Med       Date:  2015-06       Impact factor: 5.344

5.  Videothoracoscopic resection for lung cancer: moving towards a "standard of care".

Authors:  Tom Treasure
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

6.  A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial.

Authors:  Sissel Urke Olsen; Karin Hesseberg; Anne-Marie Aas; Are Hugo Pripp; Anette Hylen Ranhoff; Asta Bye
Journal:  Eur Geriatr Med       Date:  2021-06-04       Impact factor: 1.710

Review 7.  Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness.

Authors:  David Price; Alison Chisholm; Thys van der Molen; Nicolas Roche; Elizabeth V Hillyer; Jean Bousquet
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

Review 8.  Osteoporosis: the emperor has no clothes.

Authors:  T L N Järvinen; K Michaëlsson; P Aspenberg; H Sievänen
Journal:  J Intern Med       Date:  2015-06       Impact factor: 8.989

9.  Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol.

Authors:  Anthony S Gunnell; Matthew W Knuiman; Elizabeth Geelhoed; Michael S T Hobbs; Judith M Katzenellenbogen; Joseph Hung; Jamie M Rankin; Lee Nedkoff; Thomas G Briffa; Michael Ortiz; Malcolm Gillies; Anne Cordingley; Mitch Messer; Christian Gardner; Derrick Lopez; Emily Atkins; Qun Mai; Frank M Sanfilippo
Journal:  BMJ Open       Date:  2014-09-18       Impact factor: 2.692

10.  Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.

Authors:  Richard J Martin; David Price; Nicolas Roche; Elliot Israel; Willem M C van Aalderen; Jonathan Grigg; Dirkje S Postma; Theresa W Guilbert; Elizabeth V Hillyer; Anne Burden; Julie von Ziegenweidt; Gene Colice
Journal:  NPJ Prim Care Respir Med       Date:  2014-10-09       Impact factor: 2.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.